Indivior Pharmaceuticals INDV
NASDAQ INDV
$34.79 +0.02 (+0.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

Indivior Pharmaceuticals (INDV) Other financing activities (2024 - 2026)

Updated

Indivior Pharmaceuticals (INDV) recorded Other financing activities of $21 million in Q1 2026, up 600.0% from $3 million a year earlier and up 950.0% from the prior quarter.

Analysis

Indivior Pharmaceuticals (INDV) Other financing activities (2024 - 2026) Analysis & Trends

For FY2025, Indivior Pharmaceuticals reported Other financing activities of $5 million, down 77.3% from FY2024.

  • Annual Other financing activities has a three-year compound annual growth rate of -20.6% (FY2022 to FY2025).
  • Across earlier years, Other financing activities came in at $22 million in FY2024 (unchanged), $22 million in FY2023 (+120.0%) and $10 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Indivior Pharmaceuticals 4.13 Bn 3.10 Bn 294.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.00 Mn
Mar 31, 2026 -23.00 Mn
Dec 31, 2025 -2.00 Mn
Mar 31, 2025 -3.00 Mn
Dec 31, 2024 -4.00 Mn
Sep 30, 2024 1.00 Mn
Mar 31, 2024 -21.00 Mn
API Access

Indivior Pharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=INDV&period=max&api_key=YOUR_API_KEY